Vice President, Regulatory Affairs and Quality Assurance
Terns Pharmaceuticals, Inc. (NASDAQ: TERN) is a clinical-stage biopharmaceutical company developing a portfolio of small molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs – an allosteric BCR-ABL inhibitor for CML, a small molecule GLP-1 receptor agonist, and a THR-β agonist – as well as a preclinical GIPR modulator program.
Who We Are Looking For
The Vice President, Regulatory Affairs and Quality Assurance, will lead the regulatory and quality functions for all development-stage programs. This role will focus on developing and executing regulatory strategies, managing global health authority interactions, and overseeing quality operations to ensure compliance and successful progression through clinical development and approval processes. As a member of the Senior Leadership Team, the VP will work closely with internal teams and external partners to ensure regulatory milestones are met while maintaining the highest quality standards across all projects.
What You’ll Do
What You’ll Bring to Our Team:
The expected base pay for this full-time position is $280,000 - $325,000 + bonus + equity + benefits. At Terns, our salary ranges are determined by role, level, and location. The ranges are subject to change and individual pay within that range can vary for several reasons including location, skills/capabilities, experience, and available budget.
Terns Pharmaceuticals is committed to being an Equal Opportunity Employer and our policy is to provide equal employment opportunities to all applicants and employees without regard to race, color, creed, religion, sex, sexual orientation, gender identity, marital status, citizenship status, age, national origin, ancestry, disability, veteran status, or any other legally protected status and to affirmatively seek to advance the principles of equal employment opportunity.
#J-18808-Ljbffr